Researchers have developed many new ways to treat cancer, and immunotherapy for cancer has played a large role in their discoveries. Here at Issels®, we’re proud to provide immunotherapy for cancer to our patients as a treatment alternative to chemotherapy and radiation.
In recent discoveries, extensive research has been conducted on Monoclonal Antibodies (MAbs) and the important role they play in treating cancer.
Understanding Antibodies and Their Role in the Body
When your body detects a foreign substance – whether it’s cancer cells or a common infection – your immune system immediately goes to work creating antibodies to fight what doesn’t belong in its environment. The foreign substance is called an antigen, and antibodies will search until it’s been found. Once it’s found, your immune system attacks it.
Researchers have found that by isolating certain antibodies and then reproducing them in a laboratory setting, they are able to target specific cancer cells.
How Monoclonal Antibodies are used in Immunotherapy for Cancer
Just as there are many different types of antigens, there are many types of cancers. MAbs have been shown to be effective against certain types of cancer. The challenge has been that the MAbs must be tailored to go after the right antigen, and that is causing a delay in using this treatment for all types of cancer.
Even so, research is ongoing and experts are hopeful that this new protocol might bring us one step closer to finding a cure.